Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0173160173160173 0.0173160173160173 0.0303030303030302 0.025974025974026
Stock impact report

BRIEF-Obseva Announces Publication Of Abstracts From Phase 2B Edelweiss Trial Of Linzagolix In Endometriosis [Reuters]

ObsEva SA - Common Shares (OBSV) 
Last obseva sa - common shares earnings: 3/5 01:00 am Check Earnings Report
Company Research Source: Reuters
BRIEF-Obseva Announces Publication Of Abstracts From Phase 2B Edelweiss Trial Of Linzagolix In Endometriosis April 22 (Reuters) - Obseva SA: * OBSEVA ANNOUNCES PUBLICATION OF ABSTRACTS FROM PHASE 2B EDELWEISS TRIAL OF LINZAGOLIX IN ENDOMETRIOSIS * OBSEVA SA - SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE OUTCOMES MAINTAINED OR INCREASED AFTER 52 WEEKS OF TREATMENT WITH LINZAGOLIX * OBSEVA SA - SMALL, EXPECTED, NON-CLINICALLY RELEVANT INCREASES IN SERUM LIPIDS OBSERVED AT 12 WEEKS GENERALLY STABLE AT 52 WEEKS Source text for Eikon: Further company coverage: Show less Read more
Impact Snapshot
Event Time:
OBSV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OBSV alerts
Opt-in for
OBSV alerts

from News Quantified
Opt-in for
OBSV alerts

from News Quantified